Latest news with #GarrySherriff
Business Insider
17-07-2025
- Business
- Business Insider
FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh (FCL) Receives a Hold from RBC Capital
RBC Capital analyst Garry Sherriff maintained a Hold rating on FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh on July 15 and set a price target of A$2.75. The company's shares opened today at A$2.65. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Sherriff is a 4-star analyst with an average return of 15.1% and a 67.07% success rate. Sherriff covers the Technology sector, focusing on stocks such as Xero Limited, Hansen Technologies Limited, and Technology One Limited. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh with a A$2.46 average price target.
Business Insider
05-07-2025
- Business
- Business Insider
Pro Medicus Limited (PMCUF) Gets a Hold from RBC Capital
In a report released on July 3, Garry Sherriff from RBC Capital maintained a Hold rating on Pro Medicus Limited, with a price target of A$350.00. The company's shares closed last Thursday at $203.50. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Sherriff covers the Technology sector, focusing on stocks such as Xero Limited, Wisetech Global, and Nuix Ltd.. According to TipRanks, Sherriff has an average return of 14.9% and a 66.25% success rate on recommended stocks. In addition to RBC Capital, Pro Medicus Limited also received a Hold from Bell Potter's John Hester in a report issued yesterday. However, on the same day, Morgans maintained a Sell rating on Pro Medicus Limited (Other OTC: PMCUF). Based on Pro Medicus Limited's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $97.19 million and a net profit of $51.75 million. In comparison, last year the company earned a revenue of $74.11 million and had a net profit of $36.25 million
